Virome and mycobiome roles in female reproductive tract health are increasingly recognized as potential ecosystem modulators.
This systematic scoping review investigated the impact of the virome and mycobiome on female reproductive tract (FRT) health, contrasting these findings with the traditional bacteriocentric paradigm that focuses primarily on bacteria, particularly Lactobacillus species. The review did not report a specific sample size, study phase, or setting for the included evidence. The primary outcome assessed was the role of these non-bacterial elements in FRT health.
The analysis proposed that bacteriophage function acts as a community modulator. Specifically, lytic cycles were suggested to maintain bacterial diversity, whereas lysogenic cycles might contribute to stabilizing pathogenic biofilms in dysbiosis conditions like bacterial vaginosis by introducing virulence genes. Additionally, the review noted that Candida species can transition from harmless commensals to pathogens when the protective bacterial balance is disturbed. No absolute numbers, effect sizes, p-values, or confidence intervals were reported for these outcomes.
Safety and tolerability data, including adverse events and discontinuations, were not reported in the review. The authors highlighted that future therapeutic strategies should move beyond a one-bug, one-drug approach toward ecosystem restoration. Potential targeted methods mentioned include phage therapy or vaginal microbiota transplantation. However, the review did not provide specific data to support the efficacy or safety of these interventions at this stage.
Key limitations include the lack of reported absolute numbers, effect sizes, and statistical measures for the proposed mechanisms. The evidence is observational in nature, and causality was not reported. Consequently, the practice relevance is framed as a conceptual shift rather than an immediate change in standard of care based on robust quantitative evidence.